[Dose and Radiation Quality Optimized Heavy-Ion Radiotherapy].


Journal

Igaku butsuri : Nihon Igaku Butsuri Gakkai kikanshi = Japanese journal of medical physics : an official journal of Japan Society of Medical Physics
ISSN: 1345-5354
Titre abrégé: Igaku Butsuri
Pays: Japan
ID NLM: 101125977

Informations de publication

Date de publication:
2020
Historique:
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 15 9 2020
Statut: ppublish

Résumé

The biological effectiveness of charged-particle beams depends not only on dose but also on radiation quality. The radiation quality of charged-particle beams has been most commonly represented by the linear energy transfer (LET) in radiation biology studies. We investigated a new therapeutic technique of charged-particle therapy in which two or more ion species are delivered in one treatment session for optimizing the dose and LET distributions in a patient. We refer the therapeutic technique as an Intensity Modulated composite PArtiCle Therapy (IMPACT). Helium, carbon, oxygen and neon ions are considered as ion species for the IMPACT. To demonstrate the effectiveness of the IMPACT for simultaneous optimization of dose and LET distributions, an IMPACT plan was made for a prostate case. In accordance with the prescriptions, LETs in prostate, planning target volume (PTV), and rectum could be adjusted at 80 keV/μm, at 50 keV/μm, and below 30 keV/μm, respectively, while keeping the dose to the PTV at 2 Gy uniformly. The IMPACT enables the optimization of the dose and the LET distributions in a patient, which will maximize the potential of charged-particle therapy by expanding the therapeutic window.

Identifiants

pubmed: 32238679
doi: 10.11323/jjmp.40.1_23
doi:

Substances chimiques

Carbon 7440-44-0

Types de publication

Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

23-27

Auteurs

Taku Inaniwa (T)

Department of Accelerator and Medical Physics, National Institute of Radiological Sciences, QST.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH